Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment

Abstract

MAFLD was significantly associated with increased risk of cognitive impairment, especially among MAFLD patients with a high degree of liver fibrosis, moderate-severe steatosis, or hyperglycemia.